International Journal of Surgical Pathology · 11 Nov 2026
Atypical Intraductal Proliferation in Patients With Grade Group 1-2 or No Invasive Cancer on Prostate Biopsy: An Institutional Experience
Garrett Chan, Deepika Sirohi, Chien-Kuang Cornelia Ding, Janet E Cowan, Matthew R Cooperberg, Peter R Carroll, Bradley A Stohr, Emily Chan, Nancy Y Greenlandh-index 14
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Objectives Atypical intraductal proliferation (AIP) is an intraductal proliferation in which histologic features are more atypical than high-grade prostatic intraepithelial neoplasia but fall short of diagnostic criteria of intraductal carcinoma. We performed a retrospective review of patients with AIP and low-grade or no invasive cancer and correlated with follow-up and Decipher scores. Methods Prostate biopsies from 2016 to 2022 with AIP and no invasive carcinoma, Grade Group 1 (GG1, Gleason score 3 + 3 = 6) prostatic adenocarcinoma, or Grade Group 2 (GG2, Gleason score 3 + 4 = 7) prostatic adenocarcinoma were identified. Patients with concomitant intraductal carcinoma and/or ≥ GG3 were excluded. Decipher testing, PTEN staining, and subsequent biopsy/prostatectomy data were obtained from the medical record. Adverse features at prostatectomy were defined as ≥GG3, ≥pT3a, pN1, intraductal carcinoma, or Gleason pattern 5. Results There were 51 biopsies with AIP and no invasive cancer ( n = 5), GG1 ( n = 10), or GG2 ( n = 36) from 2016 to 2022. Of 18 patients who underwent subsequent biopsy, 6 (33%) had increase in Grade Group. Of 14 patients who underwent prostatectomy, 10 (71%) showed at least one adverse feature at prostatectomy. Twelve patients (10 GG2, 2 GG1) had Decipher testing. The median Decipher for the 10 GG2 biopsies was 0.53, corresponding to intermediate Decipher risk. The median Decipher for the 2 GG1 biopsies was 0.40, corresponding to low Decipher risk. Conclusions AIP in the absence of other high-risk features at biopsy may be a harbinger of subsequent adverse pathology on follow-up. AIP is an entity that may require more frequent active surveillance in the absence of other high-risk features.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Nancy Y Greenland has the highest h-index among the authors (14).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (18)
What it cites, from open citation data, with Crossref's record of each.